Found: 16
Select item for more details and to access through your institution.
Expression and clinical significance of cytochrome c oxidase subunit IV in colorectal cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.974487
- By:
- Publication type:
- Article
Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-03016-0
- By:
- Publication type:
- Article
BMP9‐induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus‐associated hepatocellular carcinoma.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 5, p. 1, doi. 10.1002/ctm2.1247
- By:
- Publication type:
- Article
Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRb complex in hepatocellular carcinoma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1212577
- By:
- Publication type:
- Article
SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway.
- Published in:
- International Journal of Biological Sciences, 2022, v. 18, n. 14, p. 5241, doi. 10.7150/ijbs.71694
- By:
- Publication type:
- Article
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 3, p. 1, doi. 10.1038/s41419-022-04676-1
- By:
- Publication type:
- Article
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 12, p. 1, doi. 10.1038/s41419-021-04375-3
- By:
- Publication type:
- Article
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Severe delayed pulmonary toxicity following PD‐L1–specific CAR‐T cell therapy for non‐small cell lung cancer.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 10, p. 1, doi. 10.1002/cti2.1154
- By:
- Publication type:
- Article
OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02533-9
- By:
- Publication type:
- Article
Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer.
- Published in:
- Journal of Surgical Oncology, 2012, v. 106, n. 3, p. 286, doi. 10.1002/jso.22150
- By:
- Publication type:
- Article
EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment.
- Published in:
- Theranostics, 2024, v. 14, n. 13, p. 5123, doi. 10.7150/thno.100171
- By:
- Publication type:
- Article
Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer.
- Published in:
- Theranostics, 2023, v. 13, n. 5, p. 1649, doi. 10.7150/thno.80483
- By:
- Publication type:
- Article
Chimeric antigen receptor-modified T-cell therapy for platelet-derived growth factor receptor α-positive rhabdomyosarcoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article